HOCL Q 2 financial results are hereby submitted
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HOCL submitted its unaudited financial results for Q2 and H1 FY26 (ended 30 Sep 2025), both standalone and consolidated, with an unmodified audit opinion from M/s Balan & Co. Standalone revenue from operations fell sharply in Q2 to Rs 12,626.75 lakhs from Rs 17,472.08 lakhs a year ago, but H1 revenue grew about 24% YoY to Rs 29,015.55 lakhs. The company posted a standalone net loss of Rs 1,813.71 lakhs in Q2 (vs Rs 1,380.35 lakhs loss last year), while H1 net loss narrowed to Rs 2,463.59 lakhs from Rs 4,936.68 lakhs. FY25 had a large one-time profit of Rs 39,154.13 lakhs due to Government of India waiving GOI loans, preference shares, and accumulated interest. The auditor flagged emphasis-of-matter notes on going concern/restructuring, a non-performing subsidiary loan, and non-compliance with SEBI LODR board composition rules.
Losses continue but are narrowing on a half-year basis, and the GOI loan waiver has strengthened the balance sheet. However, ongoing restructuring, SEBI board-composition non-compliance, and declining quarterly revenue remain concerns for shareholders.